kaonavi
4435
D. 西醫療法研究所
4576
Itamiarts
168A
Nakayo
6715
安奈特控股
6835
(Q3)2024/12/31 | (Q1)2024/06/30 | (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | (Q3)2022/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 11.03%59.77億 | 25.46%59.8億 | 1.77%207.05億 | 10.37%52.86億 | 3.81%53.84億 | 0.48%52.69億 | -7.00%47.67億 | 6.87%203.45億 | 2.10%47.9億 | 9.47%51.86億 |
主營業務成本 | 7.54%39.23億 | 21.75%40.31億 | -0.38%140.26億 | 3.90%35.45億 | 0.62%36.48億 | -2.30%35.22億 | -3.67%33.11億 | 10.31%140.8億 | 5.42%34.12億 | 12.73%36.26億 |
毛利 | 18.36%20.54億 | 33.88%19.49億 | 6.61%66.79億 | 26.38%17.41億 | 11.21%17.35億 | 6.58%17.47億 | -13.76%14.56億 | -0.12%62.66億 | -5.27%13.78億 | 2.58%15.61億 |
營業費用 | 6.45%11.75億 | 5.55%11.41億 | 5.44%43.51億 | 9.22%11.07億 | 5.66%11.04億 | 1.72%10.59億 | 5.24%10.81億 | 5.33%41.26億 | 3.73%10.14億 | 6.51%10.45億 |
營業利潤 | 39.17%8.79億 | 115.62%8.08億 | 8.86%23.29億 | 74.16%6.34億 | 22.44%6.32億 | 15.03%6.88億 | -43.29%3.75億 | -9.17%21.39億 | -23.71%3.64億 | -4.56%5.16億 |
營業外利息收入與支出淨額 | -17.60%125萬 | 2.19%163.5萬 | -47.21%584.2萬 | -11.18%104.9萬 | -50.62%151.7萬 | -50.00%167.6萬 | -53.77%160萬 | -28.03%1,106.6萬 | -56.18%118.1萬 | -20.64%307.2萬 |
營業外利息收入 | -3.31%160.8萬 | -7.12%169.5萬 | -47.26%652.3萬 | -19.62%117.2萬 | -50.96%166.3萬 | -49.74%186.3萬 | -52.14%182.5萬 | -23.81%1,236.9萬 | -52.43%145.8萬 | -20.53%339.1萬 |
營業外利息支出 | 145.21%35.8萬 | -73.33%6萬 | -47.74%68.1萬 | -55.60%12.3萬 | -54.23%14.6萬 | -47.32%18.7萬 | -36.08%22.5萬 | 51.86%130.3萬 | -25.14%27.7萬 | -19.44%31.9萬 |
投資淨收益 | 565.89%5,804.5萬 | 40.10%5,891萬 | 26.67%7,443萬 | 135.43%3,124.1萬 | 45.42%-1,245.9萬 | 102.38%1,360萬 | -31.73%4,204.8萬 | -29.12%5,875.7萬 | -67.81%1,327萬 | -269.22%-2,282.5萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | 6.11%3,789.4萬 | -87.00%856.7萬 | 6.35%1.67億 | -100.06%-8.8萬 | 3,571.2萬 | 1,445.49%6,560.6萬 | 6,588.6萬 | -44.94%1.57億 | 207.34%1.53億 | 0 |
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | -766.14%-1,089.6萬 | -241.84%-48.2萬 | -63.98%-500.3萬 | -1,073.68%-351.5萬 | 17.67%-125.8萬 | -110.74%-8.9萬 | 94.80%-14.1萬 | -113.08%-305.1萬 | -98.54%36.1萬 | 94.16%-152.8萬 |
減:其他特殊費用 | 766.14%1,089.6萬 | 241.84%48.2萬 | 63.98%500.3萬 | 1,073.68%351.5萬 | -17.67%125.8萬 | 110.74%8.9萬 | -94.80%14.1萬 | 113.08%305.1萬 | 98.54%-36.1萬 | -94.16%152.8萬 |
其他營業外收入(費用) | 120.58%4,243.8萬 | -45.87%743萬 | -2.16%5,155.8萬 | -78.67%198.8萬 | 29.78%1,923.9萬 | 25.28%1,660.5萬 | -10.27%1,372.6萬 | 32.48%5,269.6萬 | 129.92%932.1萬 | -69.65%1,482.4萬 |
稅前利潤 | 49.44%10.08億 | 77.58%8.84億 | 8.57%26.23億 | 22.85%6.65億 | 32.38%6.74億 | 25.36%7.86億 | -32.58%4.98億 | -13.79%24.16億 | -4.13%5.41億 | -19.54%5.09億 |
所得稅 | 54.40%2.93億 | 65.79%2.49億 | -2.07%7.16億 | -11.18%1.46億 | 30.75%1.9億 | 17.27%2.3億 | -33.42%1.5億 | -2.83%7.31億 | 65.29%1.65億 | -21.42%1.45億 |
除稅後利潤 | 47.50%7.15億 | 82.66%6.36億 | 13.18%19.07億 | 37.72%5.19億 | 33.03%4.85億 | 29.03%5.56億 | -32.22%3.48億 | -17.80%16.85億 | -18.99%3.77億 | -18.76%3.64億 |
持續經營利潤 | 47.50%7.15億 | 82.66%6.36億 | 13.18%19.07億 | 37.72%5.19億 | 33.03%4.85億 | 29.03%5.56億 | -32.22%3.48億 | -17.80%16.85億 | -18.99%3.77億 | -18.76%3.64億 |
歸屬于少數股東的淨利潤 | 0 | 0 | 0 | 0 | ||||||
歸屬於母公司的淨利潤 | 47.50%7.15億 | 82.66%6.36億 | 13.18%19.07億 | 37.72%5.19億 | 33.03%4.85億 | 29.03%5.56億 | -32.22%3.48億 | -17.80%16.85億 | -18.99%3.77億 | -18.76%3.64億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 47.50%7.15億 | 82.66%6.36億 | 13.18%19.07億 | 37.72%5.19億 | 33.03%4.85億 | 29.03%5.56億 | -32.22%3.48億 | -17.80%16.85億 | -18.99%3.77億 | -18.76%3.64億 |
總派息金額 | ||||||||||
基本每股收益 | 61.21%52.3301 | 84.04%42.66 | 15.63%127.56 | 40.14%34.74 | 35.82%32.46 | 31.52%37.18 | -30.52%23.18 | -15.14%110.32 | -16.53%24.79 | -16.67%23.9 |
稀釋每股收益 | 61.21%52.3301 | 84.04%42.66 | 15.63%127.56 | 40.14%34.74 | 35.85%32.46 | 31.58%37.18 | -30.52%23.18 | -15.14%110.32 | -16.46%24.79 | -16.51%23.8935 |
每股派息 | 0 | 0 | 5.88%36 | 5.88%18 | 0 | 5.88%18 | 0 | 28.30%34 | 21.43%17 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |